705240-99-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-Amino-3-methylphenyl)acetic acid is used as an analgesic and anti-inflammatory agent for its efficacy in treating conditions such as rheumatoid arthritis, osteoarthritis, and menstrual pain. Its mechanism of action involves the inhibition of chemical production that leads to pain and inflammation, providing relief to patients suffering from these ailments.
Used in Pain Management:
Tolmetin serves as a pain reliever, addressing a wide range of painful conditions by reducing the levels of prostaglandins, which are hormones that cause pain and inflammation.
Used in Inflammation Reduction:
As an anti-inflammatory, 2-(4-Amino-3-methylphenyl)acetic acid is utilized to decrease inflammation, which is a common symptom in various diseases and injuries.
Used in Oral and Injectable Medications:
Tolmetin is available in both oral and injectable forms, catering to different patient needs and preferences for administration routes.
Used with Caution in Patients with Specific Health Conditions:
It is used with caution in individuals with a history of heart disease, high blood pressure, or stomach ulcers due to potential side effects and interactions with their conditions.
Common side effects associated with the use of 2-(4-Amino-3-methylphenyl)acetic acid may include stomach upset, headache, dizziness, and skin rash, which are important considerations for patients and healthcare providers when prescribing and using the medication.
Check Digit Verification of cas no
The CAS Registry Mumber 705240-99-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,4 and 0 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 705240-99:
(8*7)+(7*0)+(6*5)+(5*2)+(4*4)+(3*0)+(2*9)+(1*9)=139
139 % 10 = 9
So 705240-99-9 is a valid CAS Registry Number.
705240-99-9Relevant academic research and scientific papers
RORGAMMA MODULATORS AND USES THEREOF
-
Page/Page column 41; 44; 45, (2018/08/20)
The present invention provides novel compounds of formula (la) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases, or cholestatic diseases.
